Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Volkan Granit(Biohaven Pharmaceuticals (United States)), Matthew T. Duvernay(Cara Therapeutics (United States)), Tuan Vu(University of South Florida), Mehmet Tosun, Charles A. Stewart(National Cancer Institute), Michael Benatar(University of Miami), Nizar Chahin(Oregon Health & Science University), Denise Pereira(Neurology Center of Southern California), James F. Howard(University of North Carolina at Chapel Hill), Julie Steele(University of South Florida), Metin Kurtoğlu, Michael S. Singer(Wesleyan University), Krishna V. Komanduri(University of Miami), Hafsa Kamboh, Yufei Shan(Yangzhou Vocational University), Christopher M. Jewell(University of Maryland, Baltimore), Gregory Sahagian(Neurology Center of Southern California), Miloš D. Miljković(Tufts University), Jerrica Farias, Tahseen Mozaffar(University of North Carolina at Chapel Hill), Adam D. Slansky(University of North Carolina at Chapel Hill), Gabrielle DeMaria, Naraly Requena, Adam Slansky(Neurology Associates), Adam Chowdhury(Neurology Associates), Julia Kimberly Fong, Ali A. Habib(University of California, Irvine Medical Center), Maria Elena Paredes, April Tenorio, Manisha Chopra, Beverly Mackanzie Brooks, Marc H. Feinberg(Boca Raton Regional Hospital), Niraja Suresh(Regional Health), S. E. Daniel(Alzheimer's Society), Diana Dimitrova, Kelly Holley, Minhtran Ngo Casi, Cara L. Benjamin, Murat V. Kalayoglu(Unknown), Luis de la Cruz‐Merino
Cited by 255
Related Papers
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2016|1k
Factors influencing body composition in persons with spinal cord injury: a cross-sectional study
|Journal of Applied Physiology|2003|420